Abstract Berries and red fruits are important dietary sources of polyphenols [1] . In vitro and animal studies have demonstrated the bioavailability and the anti-proliferative and anticarcinogenic properties of these fruits or of their phenolic components [2, 3] . Consumption of berries may contribute to the reduction of colon cancer by mechanisms not yet understood. Gene expression analysis using microarrays allows for a more comprehensive study of the possible molecular mechanisms by which food or food components may prevent certain cancers of the gastrointestinal tract [4] . The aim of this research is to investigate the anti-proliferative effects of a polyphenol-rich berry juice on a human model of colon cancer cells and its association to transcriptional changes in relation to colon cancer.
Methodology
We investigated the effects of a commercial chokeberry (Aronia melanocarpa) juice on the human model of colon cancer Caco-2 cells. In vitro digested (pepsin + pancreatin)
[5] chokeberry juice was added to the cells in the culture medium at a nontoxic dose (final pH 7.5 and osmolarity 325 miliosmoles L-1 in the culture medium) 2 h a day for a 4-day period. The concentration of phenolics in the medium at time 0 of the incubation period was *80 lM. Control cells were treated with an equivalent mix of enzymes and salts. Cells were counted using a hemacytometer and viability measured using Trypan blue dye exclusion. Results of proliferation and viability for both control and chokeberry treated Caco-2 cells are expressed as percentage of those values obtained for untreated cells. Gene expression changes were measured using microarrays (HG_U133A_2.0 human chips, Affymetrix). Transcripts that were 1.6-fold induced or repressed were selected. The changes in mRNA levels of several selected genes were further confirmed by RT-PCR.
Results and conclusions
Exposure of Caco-2 cells to pre-digested chokeberry juice resulted in inhibition of both cell proliferation (30-40%) and viability (*20%) in comparison to untreated cells. A very low proportion of genes (0.44% of total transcripts represented in the chip) were found to change in response to the treatment and most changes were in the range 1.6-2.0-fold. Resulting altered genes were categorized into several functional groups based on gene ontology search (Fatigo, GEPAS 1.1, Bioinformatics Unit, CNIO; SOURCE, Genetics Department, Stanford University) and available literature ( Fig.1): (1) DNA processing and transcription, (2) cell signalling and signal transduction, (3) apoptosis, cell growth, proliferation, (4) cell cytoskeleton (5) RNA processing, (6) translation and protein processing, (7) transporters, metabolism, (8) other markers and response to various stimuli. A group of genes were also categorized as ''unknown'' function. Among the responsive genes we detected changes in several genes that have been reported to be related to colon carcinogenesis, tumour migration and cell proliferation. Changes in the expression levels of some of these genes were further confirmed by RT-PCR (Table 1 ). In conclusion, polyphenol-rich chokeberry exhibited anti-proliferative effects in Caco-2 cancer colon cells. Inhibition of the cells proliferation by chokeberry juice may be associated to the modulation of transcription of specific genes such as: (1) upregulation of tumor suppressors (CEACAM1 [6] and BMP2 [7] ) and (2) downregulation of genes related to tumor invasion and metastasis 
